ClinVar Miner

Submissions for variant NM_000059.3(BRCA2):c.8860T>C (p.Ser2954Pro) (rs886041145)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000656808 SCV000329144 uncertain significance not provided 2016-08-08 criteria provided, single submitter clinical testing This variant is denoted BRCA2 c.8860T>C at the cDNA level, p.Ser2954Pro (S2954P) at the protein level, and results in the change of a Serine to a Proline (TCT>CCT). Using alternate nomenclature, this variant would be defined as BRCA2 9088T>C. This variant has not, to our knowledge, been published in the literature as pathogenic or benign. BRCA2 Ser2954Pro was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, suggesting it is not a common benign variant in these populations. Since Serine and Proline differ in polarity, charge, size or other properties, this is considered a non-conservative amino acid substitution. BRCA2 Ser2954Pro occurs at a position that is not conserved and is located in the DNA binding domain (Yang 2002). In silico analyses are inconsistent regarding the effect this variant may have on protein structure and function. Based on currently available evidence, it is unclear whether BRCA2 Ser2954Pro is pathogenic or benign. We consider it to be a variant of uncertain significance.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000308900 SCV000602778 uncertain significance not specified 2016-09-12 criteria provided, single submitter clinical testing
Ambry Genetics RCV000562009 SCV000661231 uncertain significance Hereditary cancer-predisposing syndrome 2016-01-12 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Insufficient or conflicting evidence,Rarity in general population databases (dbsnp, esp, 1000 genomes)
Color RCV000562009 SCV000909499 uncertain significance Hereditary cancer-predisposing syndrome 2018-10-10 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.